Cumberland Pharmaceuticals Inc.
CPIX
$4.49
-$0.27-5.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.96M | 17.46M | 17.34M | 18.55M | 18.32M |
| Total Receivables | 11.70M | 11.31M | 11.62M | 10.65M | 9.76M |
| Inventory | 4.00M | 4.51M | 4.30M | 4.33M | 4.61M |
| Prepaid Expenses | 2.79M | 1.95M | 2.32M | 2.68M | 3.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 36.45M | 35.24M | 35.58M | 36.21M | 35.71M |
|
|
|||||
| Total Current Assets | 36.45M | 35.24M | 35.58M | 36.21M | 35.71M |
| Net Property, Plant & Equipment | 6.45M | 6.52M | 6.70M | 6.89M | 7.04M |
| Long-term Investments | 914.00K | 914.00K | 914.00K | 914.00K | 914.00K |
| Goodwill | 914.00K | 914.00K | 914.00K | 914.00K | 914.00K |
| Total Other Intangibles | 17.97M | 19.42M | 20.46M | 21.52M | 22.61M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.79M | 14.66M | 14.86M | 15.98M | 15.50M |
| Total Assets | 75.58M | 76.75M | 78.52M | 81.51M | 81.78M |
|
|
|||||
| Total Accounts Payable | 13.91M | 12.06M | 12.51M | 13.08M | 14.04M |
| Total Accrued Expenses | 9.74M | -- | -- | -- | 9.16M |
| Short-term Debt | 5.10M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 356.50K | 6.38M | 376.80K | 362.20K | 348.10K |
| Total Finance Division Other Current Liabilities | 2.51M | 12.65M | 11.87M | 12.99M | 4.43M |
| Total Other Current Liabilities | 2.51M | 12.65M | 11.87M | 12.99M | 4.43M |
| Total Current Liabilities | 31.62M | 31.09M | 24.76M | 26.43M | 27.98M |
|
|
|||||
| Total Current Liabilities | 31.62M | 31.09M | 24.76M | 26.43M | 27.98M |
| Long-Term Debt | 10.18M | 10.10M | 16.09M | 16.08M | 12.78M |
| Short-term Debt | 5.10M | -- | -- | -- | -- |
| Capital Leases | 4.94M | 5.00M | 5.10M | 5.20M | 5.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.30M | 6.09M | 6.54M | 6.61M | 6.45M |
| Total Liabilities | 53.04M | 52.28M | 52.49M | 54.32M | 52.52M |
|
|
|||||
| Common Stock & APIC | 46.82M | 46.84M | 46.87M | 46.92M | 47.09M |
| Retained Earnings | -23.97M | -22.06M | -20.52M | -19.43M | -17.49M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 22.85M | 24.78M | 26.35M | 27.49M | 29.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.85M | 24.78M | 26.35M | 27.49M | 29.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -307.50K | -309.70K | -316.80K | -299.80K | -343.60K |
| Total Equity | 22.55M | 24.47M | 26.03M | 27.19M | 29.26M |
|
|
|||||